Company Presentation • 01 May 2020 04:30
Company Presentation • 31 Jul 2020 04:30
Company Presentation • 30 Oct 2020 04:30
Company Presentation • 16 Nov 2020 23:00
Company Presentation • 16 Feb 2023 05:30
Search or
𝛼SK
𝛼SKENTITY
Seagen (SGEN US)
Seagen (SGEN US)
35
Analysis
Health Care • United States
Seagen Inc. operates as a biotechnology company. The Company discovers and develops monoclonal antibody-based drugs to treat cancer and related diseases, as well as offers antibody-drug conjugate technology designed to deliver cell-killing agents directly to tumor cells. Seagen serves customers worldwide.
morex